TY - JOUR AU - Edwards, I. R. AU - Aronson, J. K. PY - 2000 DA - 2000// TI - Adverse drug reactions: definitions, diagnosis, and management JO - Lancet VL - 356 UR - https://doi.org/10.1016/S0140-6736(00)02799-9 DO - 10.1016/S0140-6736(00)02799-9 ID - Edwards2000 ER - TY - BOOK PY - 2002 DA - 2002// TI - Safety of medicines–A guide to detecting and reporting adverse drug reactions–Why health professionals need to take actions ID - ref2 ER - TY - JOUR AU - Bates, D. W. PY - 2001 DA - 2001// TI - Costs of drug-related morbidity and mortality: enormous and growing rapidly JO - J Am Pharm Assoc VL - 41 UR - https://doi.org/10.1016/S1086-5802(16)31242-6 DO - 10.1016/S1086-5802(16)31242-6 ID - Bates2001 ER - TY - JOUR AU - Marques, J. AU - Ribeiro-Vaz, I. AU - Pereira, A. C. AU - Polonia, J. PY - 2014 DA - 2014// TI - A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal JO - Int J Pharm Pract VL - 22 UR - https://doi.org/10.1111/ijpp.12078 DO - 10.1111/ijpp.12078 ID - Marques2014 ER - TY - JOUR AU - Rottenkolber, D. AU - Schmiedl, S. AU - Rottenkolber, M. AU - Farker, K. AU - Salje, K. AU - Mueller, S. AU - Hippius, M. AU - Thuermann, P. A. AU - Hasford, J. PY - 2011 DA - 2011// TI - Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations JO - Pharmacoepidemiol Drug Saf VL - 20 UR - https://doi.org/10.1002/pds.2118 DO - 10.1002/pds.2118 ID - Rottenkolber2011 ER - TY - JOUR AU - Lazarou, J. AU - Pomeranz, B. H. AU - Corey, P. N. PY - 1998 DA - 1998// TI - Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JO - JAMA VL - 279 UR - https://doi.org/10.1001/jama.279.15.1200 DO - 10.1001/jama.279.15.1200 ID - Lazarou1998 ER - TY - JOUR AU - Bates, D. W. AU - Cullen, D. J. AU - Laird, N. AU - Petersen, L. A. AU - Small, S. D. AU - Servi, D. AU - Laffel, G. AU - Sweitzer, B. J. AU - Shea, B. F. AU - Hallisey, R. PY - 1995 DA - 1995// TI - Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group JO - JAMA VL - 274 UR - https://doi.org/10.1001/jama.1995.03530010043033 DO - 10.1001/jama.1995.03530010043033 ID - Bates1995 ER - TY - JOUR AU - Shin, Y. S. AU - Lee, Y. W. AU - Choi, Y. H. AU - Park, B. AU - Jee, Y. K. AU - Choi, S. K. AU - Kim, E. G. AU - Park, J. W. AU - Hong, C. S. PY - 2009 DA - 2009// TI - Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers JO - Pharmacoepidemiol Drug Saf VL - 18 UR - https://doi.org/10.1002/pds.1796 DO - 10.1002/pds.1796 ID - Shin2009 ER - TY - JOUR AU - Alexopoulou, A. AU - Dourakis, S. P. AU - Mantzoukis, D. AU - Pitsariotis, T. AU - Kandyli, A. AU - Deutsch, M. AU - Archimandritis, A. J. PY - 2008 DA - 2008// TI - Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece JO - Eur J Intern Med VL - 19 UR - https://doi.org/10.1016/j.ejim.2007.06.030 DO - 10.1016/j.ejim.2007.06.030 ID - Alexopoulou2008 ER - TY - JOUR AU - Montastruc, J. L. AU - Lapeyre-Mestre, M. AU - Bagheri, H. AU - Fooladi, A. PY - 2002 DA - 2002// TI - Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France JO - Fundam Clin Pharmacol VL - 16 UR - https://doi.org/10.1046/j.1472-8206.2002.00100.x DO - 10.1046/j.1472-8206.2002.00100.x ID - Montastruc2002 ER - TY - JOUR AU - Pistone, G. AU - Gurreri, R. AU - Alaimo, R. AU - Curiale, S. AU - Bongiorno, M. R. PY - 2014 DA - 2014// TI - Gender differences in adverse drug reactions in dermatological patients in west Sicily: an epidemiological study JO - J Dermatolog Treat VL - 25 UR - https://doi.org/10.3109/09546634.2013.814755 DO - 10.3109/09546634.2013.814755 ID - Pistone2014 ER - TY - JOUR AU - Onder, G. AU - Pedone, C. AU - Landi, F. AU - Cesari, M. AU - Della Vedova, C. AU - Bernabei, R. AU - Gambassi, G. PY - 2002 DA - 2002// TI - Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) JO - J Am Geriatr Soc VL - 50 UR - https://doi.org/10.1046/j.1532-5415.2002.50607.x DO - 10.1046/j.1532-5415.2002.50607.x ID - Onder2002 ER - TY - JOUR AU - Einarson, T. R. PY - 1993 DA - 1993// TI - Drug-related hospital admissions JO - Ann Pharmacother VL - 27 UR - https://doi.org/10.1177/106002809302700702 DO - 10.1177/106002809302700702 ID - Einarson1993 ER - TY - STD TI - Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, Royer RJ. Adverse drug reaction monitoring: doing it the French way. Lancet. 1985;2:1056–8. ID - ref14 ER - TY - STD TI - Alsbou M, Alzubiedi S, Alzobi H, Samhadanah NA, Alsaraireh Y, Alrawashdeh O, Aqel A, Al-Salem K. Adverse drug reactions experience in a teaching hospital in Jordan. Int J Clin Pharm. 2015;37:1188–93. ID - ref15 ER - TY - STD TI - Khan LM, Al-Harthi SE, Saadah OI, Al-Amoudi AB, Sulaiman MI, Ibrahim IM. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital. Saudi Med J. 2012;33:863–8. ID - ref16 ER - TY - STD TI - Zancan A, Locatelli C, Ramella F, Tatoni P, Bacis G, Vecchio S, Manzo L. A new model of pharmacovigilance? A pilot study. Biomed Pharmacother. 2009;63:451–5. ID - ref17 ER - TY - STD TI - Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969–2002: the importance of reporting suspected reactions. Arch Intern Med. 2005;165:1363–9. ID - ref18 ER - TY - STD TI - Cereza G, Agusti A, Pedros C, Vallano A, Aguilera C, Danes I, Vidal X, Arnau JM. Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol. 2010;66:937–45. ID - ref19 ER - TY - STD TI - Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006;54:226–33. ID - ref20 ER - TY - STD TI - Pedros C, Vallano A, Cereza G, Mendoza-Aran G, Agusti A, Aguilera C, Danes I, Vidal X, Arnau JM. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain. Drug Saf. 2009;32:77–83. ID - ref21 ER - TY - STD TI - Qing-ping S, Xiao-dong J, Feng D, Yan L, Mei-ling Y, Jin-xiu Z, Shu-qiang Z: Consequences, measurement, and evaluation of the costs associated with adverse drug reactions among hospitalized patients in China. BMC health services research 2014;14:73. ID - ref22 ER - TY - STD TI - Lee JH, Park KH, Moon HJ, Lee YW, Park JW, Hong CS. Spontaneous reporting of adverse drug reactions through electronic submission from regional society healthcare professionals in Korea. Yonsei Med J. 2012;53:1022–7. ID - ref23 ER - TY - STD TI - Yun IS, Koo MJ, Park EH, Kim SE, Lee JH, Park JW, Hong CS. A comparison of active surveillance programs including a spontaneous reporting model for phamacovigilance of adverse drug events in a hospital. Korean J Intern Med. 2012;27:443–50. ID - ref24 ER - TY - STD TI - Figueiras A, Herdeiro MT, Polonia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial. JAMA. 2006;296:1086–93. ID - ref25 ER - TY - STD TI - Backstrom M, Mjorndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions—a way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62:381–5. ID - ref26 ER - TY - STD TI - Lobo MG, Pinheiro SM, Castro JG, Momente VG, Pranchevicius MC. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil. BMC Pharmacol Toxicol. 2013;14:5. ID - ref27 ER - TY - STD TI - Baldo P, De Paoli P. Pharmacovigilance in oncology: evaluation of current practice and future perspectives. J Eval Clin Pract. 2014;20:559–69. ID - ref28 ER - TY - STD TI - Kunnoor NS, Devi P, Kamath DY, Anthony N, George J. Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit. Singap Med J. 2014;55:221–8. ID - ref29 ER - TY - STD TI - Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A, Kazemnejad A, Moin M. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf. 2009;18:104–10. ID - ref30 ER - TY - STD TI - Sauer BC, Hepler CD, Cherney B, Williamson J. Computerized indicators of potential drug-related emergency department and hospital admissions. Am J Manag Care. 2007;13:29–35. ID - ref31 ER - TY - STD TI - Colt HG, Shapiro AP. Drug‐Induced Illness as a Cause for Admission to a Community Hospital. J Am Geriatr Soc. 1989;37:323–6. ID - ref32 ER - TY - STD TI - Hunziker T, Kunzi UP, Braunschweig S, Zehnder D, Hoigne R. Comprehensive hospital drug monitoring (CHDM): adverse skin reactions, a 20-year survey. Allergy. 1997;52:388–93. ID - ref33 ER - TY - STD TI - Thong BY, Leong KP, Tang CY, Chng HH. Drug allergy in a general hospital: Results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol. 2003;90:342–7. ID - ref34 ER - TY - STD TI - Li H, Guo X-J, Ye X-F, Jiang H, Du W-M, Xu J-F, Zhang X-J, He J. Adverse drug reactions of spontaneous reports in shanghai pediatric population. PLoS One. 2014;9:e89829. ID - ref35 ER - TY - STD TI - Li YY, Xiang YY, Xie YM, Shen H. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China’s spontaneous response system]. Zhongguo Zhong Yao Za Zhi. 2013;38:2998–3002. ID - ref36 ER -